Actively Recruiting
Efficacy and Safety of Gushen Antai Pill on Ongoing Pregnancy Rate in Women With Normal Ovarian Reserve Undergoing IVF-ET
Led by Shandong University of Traditional Chinese Medicine · Updated on 2026-03-10
800
Participants Needed
1
Research Sites
289 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The purpose of this study is to investigate whether oral Gushen Antai pills supplementation for luteal phase support will improve ongoing pregnancy rate in women with normal ovarian reserve in fresh embryo transfer cycles.
CONDITIONS
Official Title
Efficacy and Safety of Gushen Antai Pill on Ongoing Pregnancy Rate in Women With Normal Ovarian Reserve Undergoing IVF-ET
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Normal ovarian function reserve (5 AFC 15, 1.2 ng/ml AMH 3.5 ng/ml)
- Regular menstrual cycle of 21 to 35 days with normal ovulation
- Undergoing initial IVF or ICSI treatment
- At least one embryo or blastocyst available for transfer
You will not qualify if you...
- Age 43 years or older
- Body mass index (BMI) 28 Kg/m2 or higher
- Using a "freeze-all" strategy
- Using natural cycle or mild stimulation for IVF/ICSI treatment
- Severe ovarian hyperstimulation syndrome during controlled ovarian stimulation
- Receiving donated oocytes or having in vitro maturation (IVM) or blastocyst biopsy for PGD or PGT-A
- History of two or more consecutive spontaneous abortions
- History of two or more previous IVF-ET failures
- Karyotype abnormalities
- Polycystic ovary syndrome
- Untreated hydrosalpinx, uterine cavity fluid, endometrial polyp, or ovarian endometriosis cyst requiring surgery during stimulation
- Congenital or acquired uterine abnormalities
- Contraindications to assisted reproductive technology or pregnancy, including uncontrolled liver or kidney problems, diabetes, hypertension, thyroid disease, heart disease, moderate to severe anemia, history of cancer or blood clots, psychiatric disorders, infections, sexually transmitted diseases, drug abuse, exposure to harmful substances, or uterine factor infertility preventing pregnancy
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
The Affiliated Hospital of Shandong University of Traditional Chinese Medicine
Jinan, Shandong, China, 250014
Actively Recruiting
Research Team
Z
Zhen-Gao Sun, M.D.
CONTACT
J
Jing-Yan Song, M.D.
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
QUADRUPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here